|
IMRX Immuneering Corp 1790340 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-17,270,427.00 |
| Balance Sheet |
|
Current Assets
|
$157,990,505.00 |
|
Assets
|
$202,055,327.00 |
|
Current Liabilities
|
$8,115,656.00 |
|
Liabilities
|
$11,320,301.00 |
|
Equity
|
$190,735,026.00 |
|
Shares Out
|
64697000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-34,934,837.00 |
|
Investing Cash Flow
|
$-52,590,874.00 |
| Market Analysis |
Market Cap
|
$339,659,250.00 |
|
Price
|
$4.48 |
|
PB
|
8.59 |
|
EPS
|
-0.27 |
|
FCF
|
$-35,042,134.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:44 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:35 |
|
| Apr |
May |
Jun |
| 2026-03-06 |
-0.18 |
|
|
2026-05-15 |
-0.21 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-13 |
-0.40 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-12 |
-0.38 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view IMRX documents filed with the SEC.
IMRX Filings
Clear
